Clinical study protocol for the treatment of moderate to severe persistent allergic rhinitis with lung-deficiency-related cold type by fire acupuncture at the Inner Yingxiang(Ex-HN09) point

Phase 1

Conditions: Allergic Rhinitis

Registration Number: ITMCTR2200006073

Lead Sponsor: Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: Not specified

Inclusion Criteria

1.Meets the agnostic criteria for allergic rhinitis with lung-deficiency-related cold type.
2.Meets the diagnostic criteria for persistent allergic rhinitis with symptom onset = 4 d/week and = 4 consecutive weeks.
3.Meets the diagnostic criteria for moderate-to-severe allergic rhinitis with severe or serious symptoms that have a significant impact on the quality of life.
4.Age between 18 and 65 years old with a disease duration of = 1 year.
5.Voluntary completion of the informed consent form, agreeing to participate in the clinical subjects.

Exclusion Criteria

1.Age <18 years or >65 years.
2.Patients with combined sinusitis, upper respiratory tract infection or asthma.
3.Patients with known presence or suspected allergy to loratadine or contraindications to its use.
4.Have used antihistamines, oral or nasal spray glucocorticoids, decongestants, mast cell membrane stabilizers, leukotriene antagonists, etc. within 14 days.
5.Patients who have received specific immunotherapy or systemic glucocorticoid treatment within the last year.
6.Patients who have received traditional medical internal or external therapies such as acupuncture, moxibustion, tui na or oral Chinese medicine within the last 1 month for allergic rhinitis.
7.Combined with tumors, serious heart, liver, kidney and other vital organs, blood and endocrine diseases.
8.Pregnancy, pregnancy preparation, breastfeeding plan within the last six months.
9.Those who have not signed informed consent.

Study & Design

Study Type: Interventional study

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total Nasal Symptom Score(TNSS);

Secondary Outcome Measures

Name	Time	Method
Rhinoconjunctivitis Quality of Life Questionnaire(RQLQ);Allergic Rhinitis Control Test Questionnaire(ARCT);Total Non-nasal Symptom Score(TNNSS);rhinomanometry;